openPR Logo
Press release

World Tuberculosis Day - Tuberculosis, the invisible pandemic

03-23-2021 01:05 PM CET | Health & Medicine

Press release from: World Infectious Disease Monitoring Organization

Tuberculosis - Woman in s Chittagong slum, Bangladesh

Tuberculosis - Woman in s Chittagong slum, Bangladesh

Tuberculosis is a disease that, every year, kills as many as COVID-19 does.

March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per year as COVID-19. Last year, tuberculosis killed 1.4 million people.

Tuberculosis or TB, occurs all around the world, but in 2019 a mere 30 countries accounted for 87% of new TB cases. Of these, eight countries accounted for two thirds of the total: India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa.

Roughly 12 million people are infected by tuberculosis per year. These are frequently people living in impoverished conditions in high population density areas. While getting ill is extremely easy in these conditions, getting a diagnosis is proportionally difficult. Tuberculosis treatment is not cheap affair. Although in many high-burden countries first-line medications are free or heavily discounted, transportation to get to health centers or well-balanced meals are not.

10% of patients will develop resistance to the first-line drugs and treatment for drug-resistant TB can be far more painstaking. Frequently these drugs are not fully subsidized, putting them out of reach of people who cannot afford them but depend on them to be cured.

Help us support people in need. With your help we can provide access to diagnostics and essential medicines to those who need it.

Noordwal 10
2513EA The Hague
Netherlands
Register ID (KvK) 78242622

Contact: info@woidmo.org

The World Infectious Disease Monitoring Organization (WoIDMo) is an NGO, that brings together a network of infectious disease specialists and individuals from around the world.

Our mission is to provide practical humanitarian aid to relieve the burden of infectious diseases, enhancing preparedness through programs that offer immediate help.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release World Tuberculosis Day - Tuberculosis, the invisible pandemic here

News-ID: 2260514 • Views: 389

More Releases for Tuberculosis

Tuberculosis Therapeutics Market Size - Forecasts to 2026
As per the research conducted by GME, the Tuberculosis Therapeutics Market will grow with a CAGR value of 6 percent by 2026. Due to increasing tuberculosis prevalence, growing government initiatives for tuberculosis knowledge & understanding, effective cooperation amongst educational & corporate players for innovative drug production, and soaring incidence of MDR and XDR cases in both developed & developing countries are catapulting the market's expansion. Browse 151 Market Data Tables and
Tuberculosis Diagnosis and Treatment Market
The Global Tuberculosis diagnosis and treatment market is relied upon to develop at a CAGR of 2.3 % amid 2017-2022. An irresistible illness caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis by and large influences the lungs yet can likewise influence different parts of the body. Inert tuberculosis is the sort of TB which don't have indications. Around 10% of inert contaminations advance to dynamic
Global Tuberculosis Diagnostics Sales Market Report 2018
The Global Tuberculosis Diagnostics Sales Market Report 2018 is a professional and in-depth study on the current state of the Tuberculosis Diagnostics industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Tuberculosis Diagnostics Industry analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This
Tuberculosis Testing Market | Analysis & Trends 2020
Key players in the Global Tuberculosis (TB) Testing Market, according to a report by Transparency Market Research, are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hain Lifescience GmbH, Hologic Inc. QIAGEN, Abbott Laboratories, Alere Inc., Epistem plc, Cepheid, bioMérieux SA, Akonni Biosystems Inc., and Sanofi. Among them, the top players namely, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, and Hain Lifescience GmbH
Tuberculosis Testing Market to Increasing Tuberculosis Awareness and Control Pro …
A new Transparency Market Research report states that the global tuberculosis testing market stood at US$1.9 bn in 2013 and is predicted to reach US$2.6 bn by 2020. It is predicted to expand at a CAGR of 4.30% from 2014 to 2020. The title of the report is “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” As per the report, the rising acceptance
Tuberculosis: A Neglected Pandemic
The German Center for Research and Innovation (GCRI), in cooperation with the Max Planck Florida Institute, will host a discussion on the treatments and challenges of tuberculosis on Thursday, March 31, from 7:00 to 9:00 p.m. The event will take place at the German House New York (871 United Nations Plaza, First Avenue, btw. 48th & 49th Streets). Tuberculosis, along with HIV/AIDS, is one of today’s deadliest threats. Killing one